Search research articles
Contact Us
Filters
Showing results (151-160 of 310) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project
Wendy B London, Victoria Castel, Tom Monclair, et al.
Diagnostics (Basel, Switzerland)
|
December 24, 2021
Validation of a Monte Carlo Modelling Based Dosimetry of Extraoral Photobiomodulation
Anna N Yaroslavsky, Amy F Juliano, Ather Adnan, et al.
Journal of Pediatric Hematology/Oncology
|
June 24, 2006
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group
Faith H Kung, Cindy L Schwartz, Carolyn R Ferree, et al.
Plos One
|
August 12, 2016
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
Shigeki Yagyu, Tomoko Iehara, Shiro Tanaka, et al.
Molecular Cancer Therapeutics
|
April 14, 2005
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
Murray D Norris, Janice Smith, Kara Tanabe, et al.
Pediatric Blood & Cancer
|
October 28, 2017
Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study
Allison F O'Neill, Stephan D Voss, Jyothi P Jagannathan, et al.
The Lancet. Child & Adolescent Health
|
January 30, 2018
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
Pedro A de Alarcon, Katherine K Matthay, Wendy B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma
Daniel von Allmen, Andrew M Davidoff, Wendy B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2004
Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891
Paul C Rogers, Thomas A Olson, John W Cullen, et al.
JCO Clinical Cancer Informatics
|
February 16, 2021
Building a Harmonized Datamart by Integrating Cross-Institutional Systems of Clinical, Outcome, and Genomic Data: The Pediatric Patient Informatics Platform (<i>PPIP</i>)
Clement Ma, Madhumitha Sridharan, Hasan Al-Sayegh, et al.
Page
of 31
Search research articles
Search
Showing results (151-160 of 310) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project
Wendy B London, Victoria Castel, Tom Monclair, et al.
Diagnostics (Basel, Switzerland)
|
December 24, 2021
Validation of a Monte Carlo Modelling Based Dosimetry of Extraoral Photobiomodulation
Anna N Yaroslavsky, Amy F Juliano, Ather Adnan, et al.
Journal of Pediatric Hematology/Oncology
|
June 24, 2006
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group
Faith H Kung, Cindy L Schwartz, Carolyn R Ferree, et al.
Plos One
|
August 12, 2016
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
Shigeki Yagyu, Tomoko Iehara, Shiro Tanaka, et al.
Molecular Cancer Therapeutics
|
April 14, 2005
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
Murray D Norris, Janice Smith, Kara Tanabe, et al.
Pediatric Blood & Cancer
|
October 28, 2017
Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study
Allison F O'Neill, Stephan D Voss, Jyothi P Jagannathan, et al.
The Lancet. Child & Adolescent Health
|
January 30, 2018
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
Pedro A de Alarcon, Katherine K Matthay, Wendy B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma
Daniel von Allmen, Andrew M Davidoff, Wendy B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2004
Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891
Paul C Rogers, Thomas A Olson, John W Cullen, et al.
JCO Clinical Cancer Informatics
|
February 16, 2021
Building a Harmonized Datamart by Integrating Cross-Institutional Systems of Clinical, Outcome, and Genomic Data: The Pediatric Patient Informatics Platform (<i>PPIP</i>)
Clement Ma, Madhumitha Sridharan, Hasan Al-Sayegh, et al.
Page
of 31